- Home
- QLYS vs OPCH Comparison
QLYS vs OPCH Comparison
Compare QLYS & OPCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | QLYS | OPCH |
|---|---|---|
| Founded | 1999 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medical/Nursing Services |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.2B | 3.5B |
| IPO Year | 2012 | 1996 |
Fundamental Metrics
Financial Performance| Metric | QLYS | OPCH |
|---|---|---|
| Price | $136.52 | $21.60 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 13 | 7 |
| Target Price | ★ $133.08 | $36.57 |
| AVG Volume (30 Days) | 828.0K | ★ 2.3M |
| Earning Date | 05-05-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 16.99 | 3.25 |
| EPS | ★ 1.42 | 0.29 |
| Revenue | $321,607,000.00 | ★ $4,998,202,000.00 |
| Revenue This Year | $9.97 | $7.21 |
| Revenue Next Year | $7.15 | $8.55 |
| P/E Ratio | $94.18 | ★ $72.69 |
| Revenue Growth | 15.32 | ★ 16.17 |
| 52 Week Low | $74.51 | $18.01 |
| 52 Week High | $167.86 | $36.80 |
Technical Indicators
Market Signals| Indicator | QLYS | OPCH |
|---|---|---|
| Relative Strength Index (RSI) | 48.06 | 50.11 |
| Support Level | $136.17 | $20.82 |
| Resistance Level | $154.54 | $22.43 |
| Average True Range (ATR) | 8.78 | 0.60 |
| MACD | -3.90 | -0.03 |
| Stochastic Oscillator | 13.71 | 49.85 |
Price Performance
Historical ComparisonAbout QLYS Qualys Inc.
Qualys is a cloud security and compliance solutions provider that helps businesses identify and manage their security risks and compliance requirements. The California-based company has more than 10,000 customers worldwide, the majority of which are small- and medium-size businesses. Qualys was founded in 1999 and went public in 2012.
About OPCH Option Care Health Inc.
Option Care Health Inc is the provider of home and alternate-site infusion services. It provides treatment for bleeding disorders, neurological disorders, heart failure, anti-infectives, and chronic inflammatory disorders, among others. The Company operates in one segment, infusion services.